Trials / Unknown

UnknownNCT05314725

Treatment With SGLT-2 Inhibitor for Postoperative Hyperglycemia in Acute Abdominal Surgery - a Randomized Trial

Status: Unknown
Phase: Phase 2
Study type: Interventional
Enrollment: 24 (estimated)

Sponsor: Zealand University Hospital · Academic / Other
Sex: All
Age: 18 Years – 85 Years
Healthy volunteers: Not accepted

Summary

The aim of the study is to investigate the effect of an SGLT-2 inhibitor on postoperative hyperglycemia after acute abdominal surgery in patients without diabetes

Conditions

Postoperative Hyperglycemia
Stress Hyperglycemia

Interventions

Type	Name	Description
DRUG	SGLT2 inhibitor	10 days of SGLT2 inhibitor after surgery
DRUG	Placebo	10 days of placebo after surgery

Timeline

Start date: 2022-06-01
Primary completion: 2023-05-01
Completion: 2023-06-01
First posted: 2022-04-06
Last updated: 2022-04-06

Source: ClinicalTrials.gov record NCT05314725. Inclusion in this directory is not an endorsement.